Is Walpar Nutritions Ltd (WALPAR) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Walpar Nutritions Ltd is a below average quality company .

Is Walpar Nutritions Ltd (WALPAR) undervalued or overvalued?

The key valuation ratios of Walpar Nutritions Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Walpar Nutritions Ltd (WALPAR) share price return in the past 10 years?

Data is not available for this company

Is Walpar Nutritions Ltd (WALPAR) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Walpar Nutritions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Walpar Nutritions Ltd (WALPAR)?

Company share prices are keep on changing according to the market conditions. The current trading price of Walpar Nutritions Ltd (WALPAR) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Walpar Nutritions?

The latest standalone P/E ratio of Walpar Nutritions as of 01-Jan-1970 is 20.52.

What is the P/B ratio of Walpar Nutritions Ltd (WALPAR)?

The latest standalone P/B ratio of Walpar Nutritions Ltd (WALPAR) as of 01-Jan-1970 is 2.32.

What is the 52-week high and low of Walpar Nutritions Ltd (WALPAR)?

The 52-week high of Walpar Nutritions Ltd (WALPAR) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Walpar Nutritions Ltd (WALPAR) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Walpar Nutritions Ltd (WALPAR)
Brand: Walpar Nutritions

Walpar Nutritions Ltd (WALPAR) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Walpar Nutritions Ltd (WALPAR)

BSE: 0 NSE: WALPAR

Key Metrics

Market Cap

₹35 Cr.

P/E Ratio

20.52

Price to Book (P/B)

2.32

Price to Sales (P/S)

0.58

EV/EBITDA

11.29

Return on Capital Employed (ROCE)

17.70%

Current Price

₹0

Return on Equity (ROE)

11.95%

Return on Assets (ROA)

6.23%

Operating Profit Margin

4.7%

Net Profit Margin

2.81%

Gross Profit Margin

4.7%

Book Value per Share

₹16

Sales Growth (YoY)

17.25%

Sales Growth (3 Years)

31%

Operating Profit Growth (1 Year)

61.36%

Operating Profit Growth (3 Years)

38.89%

Net Profit Growth (1 Year)

52.25%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

59.38%

Dividend Yield

0.00%

Promoter Holding

68.82%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Walpar Nutritions Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -19.86% based on the current price.

Q.1 Which industry/sub-sector does Walpar Nutritions Ltd belong to?

Walpar Nutritions Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Return on capital employed (ROCE) of Walpar Nutritions Ltd?

Walpar Nutritions Ltd Return on capital employed is 17.7% for FY-2025, which is above its 5-year historical median of 6.44%. The current ROCE is above its estimated weighted average cost of capital (WACC) of 14%, indicating value creation.

Q.1 Promoter shareholding and pledge status of Walpar Nutritions Ltd?

Promoters hold 68.82% of the Walpar Nutritions Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Walpar Nutritions Ltd vs industry peers?

Walpar Nutritions Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 8.30%, indicating slower growth and losing its market share.

DeciZen - make an informed investing decision on Walpar Nutritions

Based on:

Data

M-Cap below 100cr DeciZen not available

Walpar Nutritions stock performance

Key Ratios

Is Walpar Nutritions Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	3.4%	6.4%	5.4%	12%	17.7%	-
Value Creation Index ⓘ	-0.8	-0.5	-0.6	-0.1	0.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	6.1	26.8	28.7	51.3	60.2	60
Sales YoY Gr.	-	340.9%	7.3%	78.8%	17.3%	-
Adj EPS ⓘ	0.2	0.5	0.3	1.1	1.8	1.8
YoY Gr.	-	104.4%	-27.7%	232.4%	59.3%	-
BVPS (₹) ⓘ	6.9	12.1	12.4	14.2	16	16
Adj Net Profit ⓘ	0.2	0.4	0.3	1.1	1.7	2
Cash Flow from Ops. ⓘ	1.4	-0.3	1.1	3.1	2.7	-
Debt/CF from Ops. ⓘ	4	-13.8	2.9	0.1	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	31%	17.3%
Adj EPS ⓘ	NA	NA	56.5%	59.3%
BVPSⓘ	NA	NA	9.7%	12.7%
Share Price	-	-	-19.9%	-19.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	3.2	5.4	2.8	8.6	11.9	11.3
Op. Profit Mgn % ⓘ	7.7	4	2.8	3.4	4.7	NAN
Net Profit Mgn % ⓘ	2.5	1.6	1.1	2.1	2.8	2.8
Debt to Equity ⓘ	1.2	0.4	0.3	0	0	-
Working Cap Days ⓘ	0	220	232	122	119	0
Cash Conv. Cycle ⓘ	0	91	97	49	41	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	1.8	2.5
TTM Sales (₹ Cr.)	60.2	71.8
BVPS (₹) ⓘ	16	17.6
Reserves (₹ Cr.) ⓘ	6	7
P/BV ⓘ	2.32	2.10
PE ⓘ	20.52	14.95

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	34.7
Equity (₹ Cr.)	9.4
Face Value (₹)	10
Industry PE ⓘ	43.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Walpar Nutritions - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	6.07	26.76	28.70	51.31	60.16
Operating Expenses ⓘ +	5.61	25.70	27.92	49.55	57.32
Manufacturing Costs	0.06	0.22	0.20	0.23	0.37
Material Costs	4.27	20.97	24.53	45.91	53.05
Employee Cost	0.61	2.11	0.96	0.97	1.03
Other Costs ⓘ	0.68	2.39	2.23	2.44	2.88
Operating Profit ⓘ	0.46	1.06	0.78	1.76	2.84
Operating Profit Margin (%)	7.5%	4.0%	2.7%	3.4%	4.7%
Other Income ⓘ +	0	0.04	0.27	0.13	0.10
Exceptional Items ⓘ	0	0	0	0	0
Interest ⓘ	0.18	0.48	0.34	0.21	0.10
Depreciation ⓘ	0.12	0.28	0.25	0.21	0.41
Profit Before Tax ⓘ	0.16	0.34	0.46	1.48	2.43
Tax ⓘ	0.01	-0.08	0.16	0.37	0.74
Profit After Tax	0.15	0.42	0.29	1.11	1.69
PAT Margin (%)	2.5%	1.6%	1.0%	2.2%	2.8%
Adjusted EPS (₹)	0.2	0.5	0.3	1.2	1.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	4.78	11.03	11.32	13.33	15.02
Share Capital ⓘ	3.34	4.54	4.54	4.70	9.39
Reserves ⓘ	1.44	6.49	6.78	8.64	5.63
Debt +	4.51	3.06	2.85	0.32	0
Long Term Debt	2.63	1.60	1.03	0	0
Short Term Debt	1.89	1.46	1.83	0.32	0
Minority Interest	0	0	0	0	0
Trade Payables	5.09	7.47	6.70	8.44	13.63
Others Liabilities ⓘ	1.28	1.58	0.83	1.29	2.27
Total Liabilities ⓘ	15.66	23.15	21.70	23.38	30.92
Fixed Assets
Net Fixed Assets ⓘ +	1.07	0.94	0.83	1.48	2.29
Gross Block	1.18	1.34	1.48	2.30	3.52
Accumulated Depreciation	0.12	0.40	0.65	0.82	1.23
CWIP ⓘ	0	0	0.02	0.02	0.03
Investments ⓘ	0.06	2.93	2.84	4.70	4.70
Inventories	4.33	5.93	6.04	5.03	4.77
Trade Receivables	7.16	9.11	8.78	10.09	16.95
Cash Equivalents	0.97	0.34	0.37	0.45	1.51
Others Assets ⓘ	2.07	3.89	2.83	1.61	0.67
Total Assets ⓘ	15.66	23.15	21.70	23.38	30.92

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1.38	-0.32	1.09	3.13	2.71
PBT ⓘ	0.16	0.34	0.46	1.48	2.43
Adjustment ⓘ	0.30	0.76	0.59	0.35	0.51
Changes in Working Capital ⓘ	0.92	-1.34	0.12	1.42	0.1
Tax Paid ⓘ	0	-0.07	-0.08	-0.11	-0.33
Cash Flow From Investing Activity ⓘ +	-0.70	-4.58	0.46	-0.88	-1.23
Capex	-0.01	-0.16	-0.13	-0.85	-1.23
Net Investments	-0.06	-2.87	0.10	-1.81	0
Others ⓘ	-0.63	-1.55	0.48	1.78	0
Cash Flow From Financing Activity ⓘ +	-0.06	4.27	-1.52	-2.18	-0.42
Net Proceeds from Shares ⓘ	1.71	5.84	0	0.91	0
Net Proceeds from Borrowing ⓘ	-1.44	-1.02	-0.58	-1.03	0
Interest Paid ⓘ	-0.18	-0.48	-0.34	-0.21	-0.10
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	-0.14	-0.06	-0.60	-1.86	-0.32
Net Cash Flow ⓘ	0.62	-0.63	0.03	0.07	1.06

Finance Ratio

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	3.29	5.37	2.64	9.03	11.95
ROCE (%)	3.41	6.44	5.36	11.98	17.7
Asset Turnover Ratio	0.39	1.38	1.28	2.28	2.22
PAT to CFO Conversion(x)	9.2	-0.76	3.76	2.82	1.6
Working Capital Days
Receivable Days	430.40	111	113.80	67.10	82
Inventory Days	260.50	70	76.10	39.40	29.70
Payable Days	434.90	109.30	105.40	60.20	75.90

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Walpar Nutritions Ltd FAQs

The current trading price of Walpar Nutritions on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Walpar Nutritions stood at ₹34.74 Cr

The latest P/E ratio of Walpar Nutritions as of 31-Dec-1969 is 20.52.

The latest P/B ratio of Walpar Nutritions as of 31-Dec-1969 is 2.32.

The 52-week high of Walpar Nutritions is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Walpar Nutritions is ₹60.16 ( Cr.) .

About Walpar Nutritions Ltd

It is manufacturing company with wide range of Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. The company develops, manufactures and commercializes Herbo-Nutraceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under Nutraceuticals. It is also engage in trading of raw material used in manufacturing Nutraceutical products.

The company has product approvals under the license issued by FSSAI (Food Safety and Standards Authority of India) and AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy) department for manufacturing of Tablets, Capsules, Oral Liquids and Ointments and also for analysis of Chemical, Instrumental & Microbiology. It is holding WHO, HACCP, HALAL, Kosher and ISO 9001:2015 certificate issued by Independent agencies. It has also applied for patents of its three products. It has developed more than 100 formulations and 1000 brands for third party for domestic market under different segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Sports nutrition. It manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet, powders and effervescent tablets. The company manufacturing unit is located at 4-9, and 21 at Shyam Estate, Santej, Ta: Kalol, Gandhinagar.

Business area of the company

The company does third party manufacturing of Nutraceutical products on job work basis. The raw material is procured by it for which it receives order for manufacturing their semi-finished/finished Nutraceutical products. It also does marketing of products which are manufactured by it under its own brand. Its products are sold through whole seller distributors/ sales distribution channels. It is also engage in trading of raw material used in manufacturing Nutraceutical products. Such raw material is basically also raw material which is used in manufacturing of its own products.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Walpar Nutritions Ltd (WALPAR) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating